Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117904 | SCV000152179 | uncertain significance | not provided | 2013-02-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312207 | SCV000847125 | benign | Inborn genetic diseases | 2016-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001087918 | SCV001020661 | benign | Borjeson-Forssman-Lehmann syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117904 | SCV001869923 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003975033 | SCV004797734 | benign | PHF6-related disorder | 2019-08-30 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |